#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Hereditary motor and sensory neuropathy PIK3CA related overgrowth spectrum Acute graft versus host disease in liver Congenital growth hormone deficiency Acute graft versus host disease in intestine Chondrodystrophy Chronic graft versus host disease Chronic hepatitis B Myelin oligodendrocyte glycoprotein antibody-associated disease Wolfram syndrome Cystic fibrosis gastrointestinal disease Fontan procedure Solitary fibrous tumour Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Trials in Disease Cystic fibrosis – Treatment Synovial sarcoma metastatic – Life with Disease Friedreich’s ataxia – Trials in Disease Friedreich’s ataxia Cholangitis sclerosing – Trials in Disease Focal segmental glomerulosclerosis – Treatment Prolymphocytic leukaemia – Treatment Cytokine release syndrome – Trials in Disease Mantle cell lymphoma stage II – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tenofovir Disoproxil Nipocalimab Roxadustat AGALSIDASE BETA Nirmatrelvir Amlodipine [99MTC]PSMA I&S Alitretinoin Florquinitau (18F) Fluasterone Juniper Berry Oil Follitropin Delta Mirodenafil Dihydrochloride Venetoclax Pegaspargase Avb-101 FERUMOXTRAN-10 Lacosamide Imipramine Hydrochloride Gentamicin More therapies…

    Learn about Your Condition

    Small intestine adenocarcinoma Interstitial lung disease Triple negative breast cancer Arteriovenous graft thrombosis Prostate cancer recurrent Eructation HER2 negative breast cancer Femoral neck fracture Rheumatoid arthritis Torticollis Renal disorder Neonatal asphyxia Peritoneal abscess Breast cancer male Uterine leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Obinutuzumab
    • Zanubrutinib
    Spain

  • Study on Metformin for Patients with Osteosarcoma and Ewing’s Sarcoma at High Risk of Relapse

    Recruiting

    2 1 1 1
    Italy

  • Study of tovorafenib (DAY101) in children and young adults aged 6 months to 25 years with brain tumors and other solid tumors that have RAF gene changes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Tovorafenib
    Denmark Germany The Netherlands

  • PET/CT Imaging Study for Patients with Giant Cell Arteritis or Rheumatoid Arthritis Using Zirconium (89Zr) Crefmirlimab Berdoxam

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    The Netherlands

  • Study on Empagliflozin to Prevent Heart Damage in Cancer Patients Receiving Anthracycline Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chemotherapy cardiotoxicity attenuation
    Investigated Drugs:
    • Empagliflozin
    Poland

  • Study on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clopidogrel Hydrogen Sulfate
    • Dabigatran Etexilate
    • Phenprocoumon
    Germany
Previous Page
1 … 324 325 326 327 328 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!